Volume 58, Issue 12 | Clinical Pharmacokinetics

Search all Clinical Pharmacokinetics articles

Volume 58, Issue 12

December 2019

Filter by

Volume:

Sort by

Date published:

New to old Old to new

10 articles in this issue

Acknowledgement to Referees

Acknowledgement to Referees 08 November 2019 Pages: 1505 - 1510
Clinical Significance of the Plasma Protein Binding of Rifampicin in the Treatment of Tuberculosis Patients
Roger K. Verbeeck
Bonifasius S. Singu
Dan Kibuule
Commentary 22 July 2019 Pages: 1511 - 1515
Part of 1 collection:

Clinical Pharmacokinetics of Tuberculosis treatment
Towards Personalized Antithrombotic Treatments: Focus on P2Y₁₂ Inhibitors and Direct Oral Anticoagulants
Jean Terrier
Youssef Daali
Jean-Luc Reny
Review Article 27 June 2019 Pages: 1517 - 1532
Exposure-Toxicity Relationships of Mycophenolic Acid in Adult Kidney Transplant Patients
Tony K. L. Kiang
Mary H. H. Ensom
Review Article 22 July 2019 Pages: 1533 - 1552
Clinical Pharmacodynamics, Pharmacokinetics, and Drug Interaction Profile of Doravirine
Alison Boyle
Catherine E. Moss
Saye Khoo
Review Article 07 August 2019 Pages: 1553 - 1565
Factors Contributing to Fentanyl Pharmacokinetic Variability Among Diagnostically Diverse Critically Ill Children
Fanuel T. Hagos
Christopher M. Horvat
Philip E. Empey
Original Research Article 06 June 2019 Pages: 1567 - 1576
A Comprehensive Whole-Body Physiologically Based Pharmacokinetic Model of Dabigatran Etexilate, Dabigatran and Dabigatran Glucuronide in Healthy Adults and Renally Impaired Patients
Daniel Moj
Hugo Maas
Thorsten Lehr
Original Research Article 18 May 2019 Pages: 1577 - 1593
Physiologically Based Pharmacokinetic Models for Prediction of Complex CYP2C8 and OATP1B1 (SLCO1B1) Drug–Drug–Gene Interactions: A Modeling Network of Gemfibrozil, Repaglinide, Pioglitazone, Rifampicin, Clarithromycin and Itraconazole
Denise Türk
Nina Hanke
Thorsten Lehr
Original Research Article Open access 25 May 2019 Pages: 1595 - 1607
Population Pharmacokinetics of Alemtuzumab (Campath) in Pediatric Hematopoietic Cell Transplantation: Towards Individualized Dosing to Improve Outcome
Rick Admiraal
Cornelia M. Jol-van der Zijde
Robbert G. M. Bredius
Original Research Article Open access 27 May 2019 Pages: 1609 - 1620
Bayesian Population Model of the Pharmacokinetics of Venetoclax in Combination with Rituximab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia: Results from the Phase III MURANO Study
Rong Deng
Leonid Gibiansky
Dale Miles
Original Research Article 18 June 2019 Pages: 1621 - 1634